Journal of Clinical Endocrinology & Metabolism, Vol 81, 1887-1892, Copyright © 1996 by Endocrine Society

ARTICLES

High-dose growth hormone treatment of short children born small for gestational age

F de Zegher, M Maes, SE Gargosky, C Heinrichs, MV Du Caju, G Thiry, J De Schepper, M Craen, L Breysem, A Lofstrom, P Jonsson, JP Bourguignon, P Malvaux and RG Rosenfeld
Belgian Study Group for Pediatric Endocrinology, Department of Pediatrics, University of Leuven, Belgium.

The effect of GH administration was evaluated over 2 yr in 50 short, prepubertal, non-GH deficient children born small for gestational age, who had been randomly allocated to a group receiving no treatment or daily sc GH treatment at a dose of 0.2 or 0.3 IU/kg. At the start of the study, mean age was 5.2 yr, bone age was 4.0 yr, height SDS was - 3.5, height velocity SDS was -0.8, weight SDS was -2.7, and body mass index SDS was -1.9. Catch-up growth was observed in none of the untreated and all of the treated children. The response to GH treatment included a near doubling of growth velocity and of weight gain and a mean height increment of more than 2 SDS. GH treatment was associated with a distinct acceleration of bone maturation. The differences between the growth responses evoked by the two GH doses were minor. The prepubertal GH-induced catch-up growth was associated with elevated serum concentrations of insulin, insulin-like growth factor-I, insulin- like growth factor binding protein-3, and osteocalcin, whereas insulin- like growth factor-II levels remained unaltered. GH treatment was well tolerated. In conclusion, high-dose GH administration over 2 yr is emerging as a potential therapy to increase the short stature that results from insufficient catch-up growth in young children born small for gestational age. The long-term impact of this approach remains to be delineated.

This article has been cited by other articles:

				M. A. J. de Ridder, T. Stijnen, and A. C. S. Hokken-Koelega Prediction Model for Adult Height of Small for Gestational Age Children at the Start of Growth Hormone Treatment J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 477 - 483. [Abstract] [Full Text] [PDF]

				P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter Small for Gestational Age: Short Stature and Beyond Endocr. Rev., April 1, 2007; 28(2): 219 - 251. [Abstract] [Full Text] [PDF]

				M. van Dijk, P. Mulder, M. Houdijk, J. Mulder, K. Noordam, R. J. Odink, C. Rongen-Westerlaken, P. Voorhoeve, J. Waelkens, J. Stokvis-Brantsma, et al. High Serum Levels of Growth Hormone (GH) and Insulin-Like Growth Factor-I (IGF-I) during High-Dose GH Treatment in Short Children Born Small for Gestational Age J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1390 - 1396. [Abstract] [Full Text] [PDF]

				F. de Zegher and A. Hokken-Koelega Growth Hormone Therapy for Children Born Small for Gestational Age: Height Gain Is Less Dose Dependent Over the Long Term Than Over the Short Term Pediatrics, April 1, 2005; 115(4): e458 - e462. [Abstract] [Full Text] [PDF]

				L B Johnston and M O Savage Should recombinant human growth hormone therapy be used in short small for gestational age children? Arch. Dis. Child., August 1, 2004; 89(8): 740 - 744. [Abstract] [Full Text] [PDF]

				P. A. Lee, J. W. Kendig, and J. R. Kerrigan Persistent Short Stature, Other Potential Outcomes, and the Effect of Growth Hormone Treatment in Children Who Are Born Small for Gestational Age Pediatrics, July 1, 2003; 112(1): 150 - 162. [Full Text] [PDF]

				T. Sas, P. Mulder, and A. Hokken-Koelega Body Composition, Blood Pressure, and Lipid Metabolism before and during Long-Term Growth Hormone (GH) Treatment in Children with Short Stature Born Small for Gestational Age Either with or without GH Deficiency J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3786 - 3792. [Abstract] [Full Text]

				F. de Zegher, K. Albertsson-Wikland, H. A. Wollmann, P. Chatelain, J.-L. Chaussain, A. Löfström, B. Jonsson, and R. G. Rosenfeld Growth Hormone Treatment of Short Children Born Small for Gestational Age: Growth Responses with Continuous and Discontinuous Regimens Over 6 Years J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2816 - 2821. [Abstract] [Full Text]

				M. L. Vance and N. Mauras Growth Hormone Therapy in Adults and Children N. Engl. J. Med., October 14, 1999; 341(16): 1206 - 1216. [Full Text] [PDF]

				T. Sas, W. de Waal, P. Mulder, M. Houdijk, M. Jansen, M. Reeser, and A. Hokken-Koelega Growth Hormone Treatment in Children with Short Stature Born Small for Gestational Age: 5-Year Results of a Randomized, Double-Blind, Dose-Response Trial J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3064 - 3070. [Abstract] [Full Text]

				F. de Zegher, M. V. L. Du Caju, C. Heinrichs, M. Maes, J. De Schepper, M. Craen, K. Vanweser, P. Malvaux, and R. G. Rosenfeld Early, Discontinuous, High Dose Growth Hormone Treatment to Normalize Height and Weight of Short Children Born Small for Gestational Age: Results Over 6 Years J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1558 - 1561. [Abstract] [Full Text]

				Z.-C. Luo, K. Albertsson-Wikland, and J. Karlberg Length and Body Mass Index at Birth and Target Height Influences on Patterns of Postnatal Growth in Children Born Small for Gestational Age Pediatrics, December 1, 1998; 102 (6): e72 - e72. [Abstract] [Full Text] [PDF]

				J. Leger, C. Garel, A. Fjellestad-Paulsen, M. Hassan, and P. Czernichow Human Growth Hormone Treatment of Short-Stature Children Born Small for Gestational Age: Effect on Muscle and Adipose Tissue Mass during a 3-Year Treatment Period and after 1 Year's Withdrawal J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3512 - 3516. [Abstract] [Full Text]

				J. C. Achermann, K. Hamdani, P. C. Hindmarsh, and C. G. D. Brook Birth Weight Influences the Initial Response to Growth Hormone Treatment in Growth Hormone-insufficient Children Pediatrics, August 1, 1998; 102(2): 342 - 345. [Abstract] [Full Text] [PDF]

				R. Coutant, J.-C. Carel, M. Letrait, C. Bouvattier, P. Chatelain, J. Coste, and J.-L. Chaussain Short Stature Associated with Intrauterine Growth Retardation: Final Height of Untreated and Growth Hormone-Treated Children J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1070 - 1074. [Abstract] [Full Text]

				F. d. Zegher, I. Francois, m. van helvoirt, and g. van den berghe Small as Fetus and Short as Child: From Endogenous to Exogenous Growth Hormone J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2021 - 2026. [Full Text] [PDF]

				M. Boguszewski, R. Bjarnason, S. Rosberg, L. M. S. Carlsson, and K. Albertsson-Wikland Growth Hormone (GH)-Binding Protein in Prepubertal Short Children Born Small for Gestational Age: Effects of Growth Hormone Treatment J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1014 - 1019. [Abstract] [Full Text] [PDF]